JP2010150292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010150292A5 JP2010150292A5 JP2010069010A JP2010069010A JP2010150292A5 JP 2010150292 A5 JP2010150292 A5 JP 2010150292A5 JP 2010069010 A JP2010069010 A JP 2010069010A JP 2010069010 A JP2010069010 A JP 2010069010A JP 2010150292 A5 JP2010150292 A5 JP 2010150292A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- polyvinylpyrrolidone
- olopatadine
- solution
- polyvinyl pyrrolidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 13
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 13
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims 7
- 229960004114 olopatadine Drugs 0.000 claims 7
- 239000000243 solution Substances 0.000 claims 5
- 230000000172 allergic effect Effects 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30131501P | 2001-06-27 | 2001-06-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009048628A Division JP2009114213A (ja) | 2001-06-27 | 2009-03-02 | 局所投与のためのオロパタジン処方物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012035170A Division JP5328947B2 (ja) | 2001-06-27 | 2012-02-21 | 局所投与のためのオロパタジン処方物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010150292A JP2010150292A (ja) | 2010-07-08 |
| JP2010150292A5 true JP2010150292A5 (enExample) | 2012-04-05 |
Family
ID=23162841
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508332A Expired - Lifetime JP4827374B2 (ja) | 2001-06-27 | 2002-06-19 | 局所投与のためのオロパタジン処方物 |
| JP2009048628A Withdrawn JP2009114213A (ja) | 2001-06-27 | 2009-03-02 | 局所投与のためのオロパタジン処方物 |
| JP2010069010A Withdrawn JP2010150292A (ja) | 2001-06-27 | 2010-03-24 | 局所投与のためのオロパタジン処方物 |
| JP2012035170A Expired - Lifetime JP5328947B2 (ja) | 2001-06-27 | 2012-02-21 | 局所投与のためのオロパタジン処方物 |
| JP2013061887A Withdrawn JP2013127005A (ja) | 2001-06-27 | 2013-03-25 | 局所投与のためのオロパタジン処方物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508332A Expired - Lifetime JP4827374B2 (ja) | 2001-06-27 | 2002-06-19 | 局所投与のためのオロパタジン処方物 |
| JP2009048628A Withdrawn JP2009114213A (ja) | 2001-06-27 | 2009-03-02 | 局所投与のためのオロパタジン処方物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012035170A Expired - Lifetime JP5328947B2 (ja) | 2001-06-27 | 2012-02-21 | 局所投与のためのオロパタジン処方物 |
| JP2013061887A Withdrawn JP2013127005A (ja) | 2001-06-27 | 2013-03-25 | 局所投与のためのオロパタジン処方物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6995186B2 (enExample) |
| EP (1) | EP1399127B1 (enExample) |
| JP (5) | JP4827374B2 (enExample) |
| KR (1) | KR100884711B1 (enExample) |
| CN (1) | CN1211125C (enExample) |
| AR (1) | AR034619A1 (enExample) |
| AT (1) | ATE295149T1 (enExample) |
| AU (1) | AU2002310461B2 (enExample) |
| BR (1) | BRPI0210707B8 (enExample) |
| CA (1) | CA2447924C (enExample) |
| DE (1) | DE60204142T2 (enExample) |
| DK (1) | DK1399127T3 (enExample) |
| ES (1) | ES2238574T3 (enExample) |
| GC (1) | GC0000397A (enExample) |
| MX (1) | MXPA03011947A (enExample) |
| PL (1) | PL205565B1 (enExample) |
| PT (1) | PT1399127E (enExample) |
| TW (1) | TWI231759B (enExample) |
| WO (1) | WO2003002093A1 (enExample) |
| ZA (1) | ZA200308771B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100055152A1 (en) * | 2008-08-26 | 2010-03-04 | Trutek Corporation | Antihistamine and antihistamine-like nasal application, products, and method |
| US7977376B2 (en) * | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
| KR101252863B1 (ko) * | 2004-04-08 | 2013-04-09 | 교와 핫꼬 기린 가부시키가이샤 | 안정성이 향상된 고형 제제 및 그 제조 방법 |
| US20070225356A1 (en) * | 2004-04-21 | 2007-09-27 | Kyowa Hakko Kogo Co., Ltd | Preventive and/or Therapeutic Agent for Chronic Sinusitis |
| MXPA06014648A (es) * | 2004-06-28 | 2007-02-12 | Alcon Inc | Formulaciones topicas para tratar pacedimientos alergicos. |
| DK1814538T3 (da) * | 2004-11-24 | 2009-11-02 | Alcon Inc | Fremgangsmåde til administration af næsespray |
| WO2006097458A1 (en) * | 2005-03-15 | 2006-09-21 | Nycomed Gmbh | Novel combination |
| WO2007007863A1 (en) | 2005-07-08 | 2007-01-18 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
| US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
| US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
| TWI409081B (zh) | 2006-11-09 | 2013-09-21 | Alcon Res Ltd | 用於藥物輸送之水不溶性聚合物基質 |
| BRPI0720431A2 (pt) * | 2006-12-18 | 2013-12-31 | Alcon Res Ltd | Dispositivos e métodos para a distribuição de fármaco oftálmico |
| WO2008093358A2 (en) * | 2007-01-29 | 2008-08-07 | Sun Pharmaceutical Industries Limited | Aqueous topical solution containing olopatadine |
| WO2008097220A1 (en) * | 2007-02-07 | 2008-08-14 | Alcon, Inc. | Olopatadine formulations for topical nasal administration |
| WO2008120249A1 (en) * | 2007-03-30 | 2008-10-09 | Sifi S.P.A. | Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| RU2009141592A (ru) * | 2007-04-11 | 2011-05-20 | Алькон Рисерч, Лтд. (Us) | ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА |
| US20100227917A1 (en) * | 2007-09-06 | 2010-09-09 | Masashi Nakakura | EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE |
| BRPI0912985A2 (pt) * | 2008-05-19 | 2015-10-13 | Alcon Res Ltd | composições farmacêuticas com polímero de carboxivinila e polímero de povidona |
| CN102089039B (zh) * | 2008-08-26 | 2013-10-23 | 博磊科技股份有限公司 | 带静电荷口罩过滤产品和用于增加过滤效率的方法 |
| KR20110056526A (ko) * | 2008-08-28 | 2011-05-30 | 트루텍 코프. | 항히스타민 및 유사-항히스타민 코 외용약, 생성물 및 방법 |
| US9458198B1 (en) | 2009-06-26 | 2016-10-04 | Shire Orphan Therapies Gmbh | Cyclic peptide-based NPR-B agonists |
| AU2010273347B2 (en) * | 2009-07-17 | 2015-04-30 | Alcon Research, Ltd. | Olopatadine nasal spray regimen for children |
| WO2011027322A1 (en) * | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Extended release dosage form containing olopatadine for oral administration |
| RU2557290C2 (ru) * | 2009-09-25 | 2015-07-20 | Шайр Орфан Терапис ГмбХ | Новые агонисты npr-b |
| US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| RU2012117141A (ru) * | 2009-10-01 | 2013-11-10 | Алькон Рисерч, Лтд. | Композиции олопатадина и способы их применения |
| WO2011075471A2 (en) | 2009-12-18 | 2011-06-23 | Alcon Research, Ltd. | Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
| TW201121995A (en) | 2009-12-18 | 2011-07-01 | Alcon Res Ltd | Novel NPR-B agonists |
| CN103140215A (zh) * | 2010-07-21 | 2013-06-05 | 爱尔康研究有限公司 | 具有提高的溶解度特征的药物组合物 |
| US20120264681A1 (en) * | 2010-11-08 | 2012-10-18 | Healor Ltd. | Buffered ophthalmic compositions and methods of use thereof |
| TWI544922B (zh) * | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物 |
| CN102885767A (zh) * | 2012-11-02 | 2013-01-23 | 江苏吉贝尔药业有限公司 | 一种新的盐酸奥洛他定滴眼液及其制备方法 |
| MA47418A (fr) | 2017-02-01 | 2021-06-02 | Takeda Pharmaceuticals Co | Composés et compositions pour le traitement de troubles ophtalmiques |
| JP7037349B2 (ja) * | 2017-06-23 | 2022-03-16 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
| WO2018235935A1 (ja) * | 2017-06-23 | 2018-12-27 | 参天製薬株式会社 | 水溶性粘稠化剤を含有する医薬組成物 |
| JPWO2021112240A1 (enExample) * | 2019-12-06 | 2021-06-10 | ||
| TWI896607B (zh) * | 2020-03-31 | 2025-09-11 | 日商參天製藥股份有限公司 | 填充於樹脂製容器之含銀鹽眼科用水性組合物 |
| CN111700860A (zh) * | 2020-07-09 | 2020-09-25 | 浙江尖峰药业有限公司 | 盐酸奥洛他定滴眼液及其制备方法 |
| CN119318630B (zh) * | 2024-10-16 | 2025-08-22 | 苏州欧康维视生物科技有限公司 | 一种阿托品药物组合物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4370324A (en) | 1980-09-17 | 1983-01-25 | Bernstein Joel E | Method and composition for treating and preventing irritation of the eyes |
| US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) * | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| ES2053678T3 (es) * | 1987-11-13 | 1994-08-01 | Asta Medica Ag | Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular. |
| IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
| JP3662944B2 (ja) | 1993-08-24 | 2005-06-22 | 協和醗酵工業株式会社 | 点鼻剤 |
| US5897858A (en) * | 1994-02-03 | 1999-04-27 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions exhibiting increased retention in the nasal cavity |
| US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| WO1998056381A1 (en) * | 1997-06-09 | 1998-12-17 | Bridge Pharma, Inc. | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use |
| DK1037627T3 (da) | 1998-07-14 | 2001-10-01 | Alcon Lab Inc | Anvendelse af 11-(3-dimethylamino-propyliden)-6, 11-dihydrodibenz[b,e]oxepin-2-eddikesyre og af farmaceutisk acceptable salte deraf til fremstillingen af et lægemiddel til behandlingen af non-allergiske... |
| US6146622A (en) | 1998-10-27 | 2000-11-14 | Alcon Laboratories, Inc. | Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| AU753462B2 (en) * | 1998-10-27 | 2002-10-17 | Alcon Laboratories, Inc. | Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| US6274626B1 (en) * | 1998-12-22 | 2001-08-14 | Bausch & Lomb Incorporated | Pheniramine-containing compositions and method for treating allergic responses |
| US6174914B1 (en) * | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
| AU7363700A (en) | 1999-09-21 | 2001-04-24 | Alcon Laboratories, Inc. | Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| US6649602B1 (en) | 1999-11-18 | 2003-11-18 | Alcon, Inc. | Use of an H1 antagonist and a safe steroid to treat eye conditions |
| ATE291913T1 (de) | 2000-01-25 | 2005-04-15 | Alcon Inc | Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen |
| AR031135A1 (es) | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| BR0316203A (pt) | 2002-11-12 | 2005-10-04 | Alcon Inc | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica |
-
2002
- 2002-06-18 TW TW091113234A patent/TWI231759B/zh not_active IP Right Cessation
- 2002-06-19 DE DE60204142T patent/DE60204142T2/de not_active Expired - Lifetime
- 2002-06-19 WO PCT/US2002/019417 patent/WO2003002093A1/en not_active Ceased
- 2002-06-19 CA CA002447924A patent/CA2447924C/en not_active Expired - Lifetime
- 2002-06-19 US US10/175,106 patent/US6995186B2/en not_active Expired - Lifetime
- 2002-06-19 PT PT02737539T patent/PT1399127E/pt unknown
- 2002-06-19 ES ES02737539T patent/ES2238574T3/es not_active Expired - Lifetime
- 2002-06-19 EP EP02737539A patent/EP1399127B1/en not_active Expired - Lifetime
- 2002-06-19 CN CNB028120434A patent/CN1211125C/zh not_active Expired - Lifetime
- 2002-06-19 BR BRPI0210707A patent/BRPI0210707B8/pt not_active IP Right Cessation
- 2002-06-19 AU AU2002310461A patent/AU2002310461B2/en not_active Expired
- 2002-06-19 KR KR1020037014821A patent/KR100884711B1/ko not_active Expired - Lifetime
- 2002-06-19 DK DK02737539T patent/DK1399127T3/da active
- 2002-06-19 MX MXPA03011947A patent/MXPA03011947A/es active IP Right Grant
- 2002-06-19 AT AT02737539T patent/ATE295149T1/de active
- 2002-06-19 PL PL367780A patent/PL205565B1/pl unknown
- 2002-06-19 JP JP2003508332A patent/JP4827374B2/ja not_active Expired - Lifetime
- 2002-06-22 GC GCP20022092 patent/GC0000397A/en active
- 2002-06-24 AR ARP020102365A patent/AR034619A1/es not_active Application Discontinuation
-
2003
- 2003-11-11 ZA ZA2003/08771A patent/ZA200308771B/en unknown
-
2005
- 2005-03-15 US US11/079,996 patent/US7402609B2/en not_active Expired - Lifetime
-
2009
- 2009-03-02 JP JP2009048628A patent/JP2009114213A/ja not_active Withdrawn
-
2010
- 2010-03-24 JP JP2010069010A patent/JP2010150292A/ja not_active Withdrawn
-
2012
- 2012-02-21 JP JP2012035170A patent/JP5328947B2/ja not_active Expired - Lifetime
-
2013
- 2013-03-25 JP JP2013061887A patent/JP2013127005A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012107046A5 (enExample) | ||
| JOP20210290A1 (ar) | مشتقات حمض إيتاكونيك واستخداماتها في علاج مرض التهابي أو مرض مصاحب لاستجابة مناعية غير مرغوب فيها | |
| UA110054C2 (uk) | Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування | |
| DK3045456T3 (da) | Bicyklisk substituerede uraciler og anvendelse heraf | |
| EA201100613A1 (ru) | Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций | |
| JP2016513069A5 (enExample) | ||
| JP2013172741A5 (enExample) | ||
| WO2011158042A3 (en) | Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections | |
| EA201590890A1 (ru) | Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу | |
| WO2011113606A8 (en) | Anti-infective compounds | |
| JP2011037901A5 (enExample) | ||
| MY173422A (en) | Purine derivatives for the treatment of viral infections | |
| CN102036649A8 (zh) | 精氨酸盐及其治疗口腔疾病的用途 | |
| UA114888C2 (uk) | Шипуча композиція у твердій формі для використання у вагінальних аплікаціях для лікування вагінальних інфекцій | |
| JP2014139241A5 (enExample) | ||
| CN110891953A (zh) | 吡咯并三嗪类衍生物、其制备方法及其用途 | |
| NZ616764A (en) | Mannose derivatives as antagonists of bacterial adhesion | |
| JP2012149097A5 (enExample) | ||
| WO2014036445A3 (en) | Novel mucolytic agents | |
| WO2015056237A3 (en) | Purification of proteins | |
| PH12014501937B1 (en) | Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative | |
| JP2012199532A5 (enExample) | ||
| JP2014521346A5 (enExample) | ||
| JP2020070301A5 (enExample) | ||
| CO7101247A2 (es) | Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas |